We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

8 hedge funds and large institutions have $28K invested in PDL BioPharma, Inc. in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more funds holding

Funds holding: 7 → 8 (+1)

0% less capital invested

Capital invested by funds: $28K → $28K (-$3)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PDLI Hedge Fund Activity: Q3 2025 in Review

8 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q3 2025, worth a combined $28K — down 0.01% from $28K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PDLI positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

  • 8 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q3 2025, up from 7 in Q2 2025.
  • Funds reported $28K of PDL BioPharma, Inc. stock for Q3 2025, down 0.01% quarter-over-quarter.
  • 2 funds opened new PDL BioPharma, Inc. positions in Q3 2025 and 0 closed out, a net change of +2 holders.

Based on aggregated 13F filings for Q3 2025.